XML 55 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense
The following table presents the details of the Company's share-based compensation expense (in millions):
Fiscal Year Ended March 31,
202320222021
Cost of sales (1)
$27.2 $34.3 $26.6 
Research and development83.1 97.9 96.8 
Selling, general and administrative60.1 78.0 74.9 
Pre-tax effect of share-based compensation170.4 210.2 198.3 
Income tax benefit36.4 44.6 42.3 
Net income effect of share-based compensation$134.0 $165.6 $156.0 
 
(1) During the fiscal year ended March 31, 2023, $19.7 million of share-based compensation expense was capitalized to inventory and $27.2 million of previously capitalized share-based compensation expense in inventory was sold. During the fiscal year ended March 31, 2022, $21.2 million of share-based compensation expense was capitalized to inventory and $34.3 million of previously capitalized share-based compensation expense in inventory was sold. During the fiscal year ended March 31, 2021, $16.7 million of share-based compensation expense was capitalized to inventory and $26.6 million of previously capitalized share-based compensation expense in inventory was sold.
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
RSUs and PSUs share activity is set forth below:
Number of
Shares
Weighted Average Grant Date Fair Value
Nonvested shares at March 31, 202011,484,106 $38.06 
Granted4,678,494 $50.69 
Forfeited(514,110)$41.69 
Vested(3,764,672)$32.07 
Nonvested shares at March 31, 202111,883,818 $44.77 
Granted2,995,991 $74.36 
Forfeited(978,325)$51.17 
Vested(3,795,469)$43.77 
Nonvested shares at March 31, 202210,106,015 $53.30 
Granted3,226,654 $61.71 
Forfeited(864,262)$55.77 
Vested(3,423,935)$45.08 
Nonvested shares at March 31, 20239,044,472 $59.17